L. Nolan

1.5k total citations
13 papers, 244 citations indexed

About

L. Nolan is a scholar working on Oncology, Epidemiology and Cancer Research. According to data from OpenAlex, L. Nolan has authored 13 papers receiving a total of 244 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Epidemiology and 4 papers in Cancer Research. Recurrent topics in L. Nolan's work include Neuroendocrine Tumor Research Advances (3 papers), Lung Cancer Research Studies (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). L. Nolan is often cited by papers focused on Neuroendocrine Tumor Research Advances (3 papers), Lung Cancer Research Studies (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). L. Nolan collaborates with scholars based in United Kingdom, Ireland and United States. L. Nolan's co-authors include Peter Johnson, A. Ganesan, Simon J. Crabb, Graham Packham, T. C. M. Morris, Z. R. Desai, A. E. Irvine, Susan Price, Mary Drake and Christian H. Ottensmeier and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

L. Nolan

10 papers receiving 238 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Nolan United Kingdom 6 112 100 62 38 29 13 244
M. Georget France 5 78 0.7× 78 0.8× 74 1.2× 40 1.1× 37 1.3× 6 287
Joshua M. Eichhorn United States 6 94 0.8× 177 1.8× 43 0.7× 26 0.7× 14 0.5× 14 280
E. L. Woodward Sweden 8 50 0.4× 113 1.1× 42 0.7× 25 0.7× 13 0.4× 14 225
Toshie Ogasawara Japan 8 73 0.7× 114 1.1× 128 2.1× 46 1.2× 23 0.8× 25 280
Anasuya Vishvanath New Zealand 8 93 0.8× 242 2.4× 113 1.8× 25 0.7× 9 0.3× 8 395
Céline Bourgne France 9 39 0.3× 110 1.1× 44 0.7× 12 0.3× 42 1.4× 26 271
Stephanie A. Schnell United States 5 70 0.6× 279 2.8× 71 1.1× 21 0.6× 28 1.0× 5 408
Stefanie Kreutmair Germany 9 49 0.4× 88 0.9× 53 0.9× 15 0.4× 24 0.8× 21 173
Shlomzion Aumann Israel 7 51 0.5× 97 1.0× 53 0.9× 24 0.6× 8 0.3× 25 160
Andrej Lissat Germany 7 43 0.4× 94 0.9× 19 0.3× 31 0.8× 6 0.2× 17 181

Countries citing papers authored by L. Nolan

Since Specialization
Citations

This map shows the geographic impact of L. Nolan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Nolan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Nolan more than expected).

Fields of papers citing papers by L. Nolan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Nolan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Nolan. The network helps show where L. Nolan may publish in the future.

Co-authorship network of co-authors of L. Nolan

This figure shows the co-authorship network connecting the top 25 collaborators of L. Nolan. A scholar is included among the top collaborators of L. Nolan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Nolan. L. Nolan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Nolan, L., et al.. (2024). Risk of locoregional recurrence after breast cancer surgery by molecular subtype—a systematic review and network meta-analysis. Irish Journal of Medical Science (1971 -). 193(6). 2965–2974.
3.
4.
Tanno, Luciana Kase, Arjun Takhar, Judith Cave, et al.. (2017). Proactive multi-modality treatment of Pancreatic Neuroendocrine Tumours (PNETs): Potential survival benefits. Pancreatology. 18(3). 304–312. 2 indexed citations
5.
Arpí, Oriol, Álvaro Taus, Pedro Rocha, et al.. (2017). Assessment of neuronal autoantibodies in patients with small cell lung cancer treated with chemotherapy with or without ipilimumab. OncoImmunology. 7(2). e1395125–e1395125. 27 indexed citations
6.
Killick, Emma, J.A. Bennett, Andrew Bates, et al.. (2014). 26 Treatment and outcome in epidermal growth factor receptor mutant non-small cell lung cancer: A retrospective audit across four NHS trusts. Lung Cancer. 83. S10–S11. 1 indexed citations
7.
Ottensmeier, Christian H., Ian Galea, Tom Maishman, et al.. (2014). A Novel Phase Ii Trial of Ipilimumab, Carboplatin and Etoposide (Ice) for the First Line Treatment of Extensive Stage Small Cell Lung Cancer (Sclc). Annals of Oncology. 25. iv516–iv516. 5 indexed citations
8.
Nolan, L., Diana Eccles, Gillian Crawford, et al.. (2009). First case report of Muir–Torre syndrome associated with non-small cell lung cancer. Familial Cancer. 8(4). 359–362. 16 indexed citations
9.
Nolan, L., Peter Johnson, A. Ganesan, Graham Packham, & Simon J. Crabb. (2008). Will histone deacetylase inhibitors require combination with other agents to fulfil their therapeutic potential?. British Journal of Cancer. 99(5). 689–694. 76 indexed citations
10.
Nolan, L., Paul Lorigan, James Newman, et al.. (2007). Low‐dose lenograstim is as effective as standard dose in shortening neutrophil engraftment time following myeloablative chemotherapy and peripheral blood progenitor cell rescue. British Journal of Haematology. 137(5). 436–442. 5 indexed citations
11.
Drake, Mary, T. C. M. Morris, L. Nolan, et al.. (1997). Analysis of the effect of prior therapy on progenitor cell yield: use of a chemotherapy scoring system. British Journal of Haematology. 98(3). 745–749. 65 indexed citations
12.
Hilgard, P., et al.. (1991). Investigation into the immunological effects of miltefosine, a new anticancer agent under development. Journal of Cancer Research and Clinical Oncology. 117(5). 403–408. 24 indexed citations
13.
Morris, Curly, H. Denis Alexander, L. Nolan, et al.. (1990). Monocyte esterase deficiency in malignant neoplasia.. Journal of Clinical Pathology. 43(4). 282–286. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Georget Breakdown of academic impact, for papers by Joshua M. Eichhorn Breakdown of academic impact, for papers by E. L. Woodward Breakdown of academic impact, for papers by Toshie Ogasawara Breakdown of academic impact, for papers by Anasuya Vishvanath Breakdown of academic impact, for papers by Céline Bourgne Breakdown of academic impact, for papers by Stephanie A. Schnell Breakdown of academic impact, for papers by Stefanie Kreutmair Breakdown of academic impact, for papers by Shlomzion Aumann Breakdown of academic impact, for papers by Andrej Lissat
Rankless by CCL
2026